<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Free radicals are known to cause secondary neuronal damage in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion (I/R) </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated here the neuroprotective effect of <z:chebi fb="0" ids="27881">resveratrol</z:chebi>, a potent <z:chebi fb="11" ids="22586">antioxidant</z:chebi> present in grape seed, against cerebral I/R-induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunctions in hippocampus </plain></SENT>
<SENT sid="2" pm="."><plain>Transient rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> was used to induce <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> (10(-7) g/kg) was given twice intravenously: 15 min pre-occlusion and at the time of reperfusion (2 h post-occlusion) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> significantly restored ATP content and the activity of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory complexes in <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treated group which were severely altered in MCAO group </plain></SENT>
<SENT sid="5" pm="."><plain>Western blot analysis showed a marked decrease in <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release as a result of <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Electrophoretic migration of hippocampal genomic DNA showed a marked decrease in DNA fragmentation after <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Notably, expression of Hsp70 and metallothionein (MT) was significantly higher in MCAO group but their expression was more significant in <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treated group </plain></SENT>
<SENT sid="8" pm="."><plain>The status of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), <z:chebi fb="105" ids="17234">glucose</z:chebi> 6-phosphate dehydrogenase (G6-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) and serum <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH) was restored by <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatment with a significant decrease in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation (LPO), protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi> and intracellular <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> content </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> significantly improved neurological deficits assessed by different scoring methods </plain></SENT>
<SENT sid="10" pm="."><plain>Also, the brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:hpo ids='HP_0002181'>brain edema</z:hpo> were significantly reduced </plain></SENT>
<SENT sid="11" pm="."><plain>Histological analysis of CA1 hippocampal region revealed that <z:chebi fb="0" ids="27881">resveratrol</z:chebi> treatment diminished intercellular and pericellular <z:hpo ids='HP_0000969'>edema</z:hpo> and glial cell infiltration </plain></SENT>
<SENT sid="12" pm="."><plain>The findings of this study highlight the ability of <z:chebi fb="0" ids="27881">resveratrol</z:chebi> in anatomical and functional preservation of ischemic neurovascular units and its relevance in the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>